Clinical Trial Update: TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement [Phase 4]

View source ↗

Summary

Completed Phase 4 trial investigating ticagrelor with rotational atherectomy to reduce troponin elevation in patients with atherosclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Atherosclerosis | Phase 4 | Status: COMPLETED